What are Xtant Medical Holdings's total assets?

Xtant Medical Holdings (XTNT) holds $78.0M in total assets, down 18.6% year over year.

How much debt does Xtant Medical Holdings have?

Xtant Medical Holdings carries $15.0M in total debt against $48.6M of shareholders' equity, a debt-to-equity ratio of 0.31.

How much cash does Xtant Medical Holdings have?

Xtant Medical Holdings holds $12.2M in cash and equivalents.

Can Xtant Medical Holdings cover its short-term obligations?

Its current ratio is 3.34 — current assets exceed current liabilities.

Where does Xtant Medical Holdings's balance sheet data come from?

Every line is extracted from Xtant Medical Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Xtant Medical Holdings XTNT Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Cash and cash equivalents	$12.16M-29.8%	$17.33M+62.8%	$10.64M+51.2%	$7.04M+29.5%	$5.44M-12.6%
Restricted cash	$20K-92.7%	$275K+14.1%	$241K+111%	$114K-71.7%	$403K+1,732%
Accounts receivable, net	$17.18M-14.1%	$20M-21.6%	$25.52M-5.3%	$26.95M+14.8%	$23.48M+6.2%
Inventories	$31.88M+5.3%	$30.26M-25.7%	$40.71M+1.4%	$40.14M+3.4%	$38.81M+0.5%
Raw materials	$6.07M+6.8%	$5.69M+1.6%	$5.6M+2.9%	$5.44M+1.0%	$5.39M-18.6%
Work in process	$5.14M+7.2%	$4.8M+5.8%	$4.54M+31.6%	$3.45M+16.4%	$2.96M+5.2%
Finished goods	$20.66M+4.5%	$19.78M-35.3%	$30.58M-2.1%	$31.25M+2.6%	$30.46M+4.3%
Prepaid expenses and other current assets	$1.4M-41.2%	$2.39M+63.9%	$1.46M-0.5%	$1.47M+3.2%	$1.42M-11.2%
Assets held for sale	——	——	——	——	——
Total current assets	$62.62M-20.0%	$78.25M-0.1%	$78.33M+3.6%	$75.59M+9.3%	$69.14M+3.0%
Property and equipment, net	$5.85M-5.6%	$6.2M-38.0%	$10.01M-4.2%	$10.45M-2.6%	$10.73M+5.9%
Accumulated depreciation	$22.45M+1.1%	$22.21M+1.6%	$21.86M+3.2%	$21.17M+3.3%	$20.5M+3.3%
Operating lease right-of-use assets	$3.05M-4.6%	$3.19M-11.8%	$3.62M+37.4%	$2.63M+258%	$736K-11.2%
Goodwill	$6.07M0.0%	$6.07M-16.8%	$7.3M0.0%	$7.3M0.0%	$7.3M0.0%
Intangible assets, net	$275K-8.0%	$299K-95.8%	$7.06M-5.8%	$7.49M-5.5%	$7.92M-5.2%
Other non-current assets	$131K-1.5%	$133K+13,200%	$1K-93.3%	$15K+1,400%	$1K-99.0%
Total assets	$78M-17.1%	$94.15M-11.5%	$106.32M+2.7%	$103.48M+8.0%	$95.83M+2.1%
Accounts payable	$5.49M+42.7%	$3.84M-43.9%	$6.86M-5.1%	$7.22M+1.4%	$7.12M-10.1%
Accrued expenses	$8.48M-20.2%	$10.63M-7.9%	$11.54M+8.6%	$10.63M+1.3%	$10.49M+35.0%
Current portion of long-term debt	$3.72M+6.3%	$3.5M+7,855%	$44K-15.4%	$52K-14.8%	$61K-11.6%
Operating lease liabilities, current	$617K-0.8%	$622K-18.2%	$760K+9.7%	$693K+7.3%	$646K-8.1%
Finance Lease Liability, Current	$35K0.0%	$35K-20.5%	$44K-15.4%	$52K-14.8%	$61K-11.6%
Liabilities held for sale	——	——	——	——	——
Income taxes payable	——	——	——	——	——
Total current liabilities	$18.77M-36.3%	$29.48M-17.0%	$35.5M+16.0%	$30.6M+3.4%	$29.58M+3.5%
Deferred tax liabilities	——	——	——	——	——
Long-term debt	$8.1M-26.6%	$11.03M-36.6%	$17.4M-21.9%	$22.28M+0.5%	$22.17M+0.6%
Operating lease liabilities, non-current	$2.53M-5.3%	$2.67M-9.6%	$2.95M+46.4%	$2.02M+1,565%	$121K-27.1%
Finance lease liabilities	$3K-75.0%	$12K-45.5%	$22K-26.7%	$30K-23.1%	$39K-17.0%
Other non-current liabilities	$5K0.0%	$5K-91.7%	$60K+11.1%	$54K+12.5%	$48K+14.3%
Total liabilities	$29.4M-31.9%	$43.19M-22.8%	$55.94M+1.7%	$54.98M+5.8%	$51.96M+2.1%
Common stock	300M0.0%	300M0.0%	300M0.0%	300M0.0%	300M0.0%
Additional paid-in capital	$306.18M+0.2%	$305.44M+0.2%	$304.79M+0.2%	$304.2M+0.2%	$303.49M+0.2%
Retained earnings	-$257.58M-1.2%	-$254.49M0.0%	-$254.54M+0.5%	-$255.85M+1.4%	-$259.4M0.0%
Accumulated other comprehensive income (loss)	——	——	$139K-8.6%	$152K+173%	-$209K+33.9%
Total stockholders' equity	$48.6M-4.6%	$50.95M+1.1%	$50.38M+3.9%	$48.5M+10.5%	$43.88M+2.1%
Total liabilities and stockholders' equity	$78M-17.1%	$94.15M-11.5%	$106.32M+2.7%	$103.48M+8.0%	$95.83M+2.1%
Allowance for Doubtful Accounts	——	——	——	——	$1.71M+18.6%
Allowance for Doubtful Accounts Receivable (Current)	$2.12M-2.3%	$2.17M+6.9%	$2.03M+12.8%	$1.8M+5.3%	$1.71M+18.6%
Total Cash, Cash Equivalents, and Restricted Cash (Inclusive)	$12.16M-29.8%	$17.33M+62.8%	$10.64M+51.2%	$7.04M+29.5%	$5.44M-12.6%
Contract Assets, Net	——	——	——	——	——
Disposal Group - Receivables, Net	——	——	——	——	——
Finance Receivables (Current)	——	——	——	——	——
Raw materials and supplies inventory, gross	$6.07M+6.8%	$5.69M+1.6%	$5.6M+2.9%	$5.44M+1.0%	$5.39M-18.6%
Other Inventory, Net	——	——	——	——	——
Deferred Tax Assets and Other Non-Current Assets	$131K-1.5%	$133K+13,200%	$1K-93.3%	$15K+1,400%	$1K-99.0%
Disposal Group - Intangible Assets, Net	——	——	——	——	——
Disposal Group - Other Assets	——	——	——	——	——
Disposal Group - Property, Plant, and Equipment (Non-Current)	——	——	——	——	——
Net Investment in Lease	$3.05M-4.6%	$3.19M-11.8%	$3.62M+37.4%	$2.63M+258%	$736K-11.2%
Net Operating Loss Carryforwards	——	——	——	——	——
Other intangible assets—net	$275K-8.0%	$299K-95.8%	$7.06M-5.8%	$7.49M-5.5%	$7.92M-5.2%
Operating lease right-of-use assets	$3.05M-4.6%	$3.19M-11.8%	$3.62M+37.4%	$2.63M+258%	$736K-11.2%
Other non-current assets	$131K-1.5%	$133K+13,200%	$1K-93.3%	$15K+1,400%	$1K-99.0%
Property, plant and equipment at cost	$28.3M-0.4%	$28.41M-10.9%	$31.87M+0.8%	$31.62M+1.3%	$31.23M+4.2%
Operating Lease Right-of-Use Assets in Other Assets	$3.05M-4.6%	$3.19M-11.8%	$3.62M+37.4%	$2.63M+258%	$736K-11.2%
Software and Technology Licenses, Net	$131K-1.5%	$133K+13,200%	$1K-93.3%	$15K+1,400%	$1K-99.0%
Tax Credit Carryforward Valuation Allowance	——	——	——	——	——
Accrued Employee Benefits	$6.24M-7.3%	$6.73M-10.8%	$7.54M+10.3%	$6.83M+7.8%	$6.34M+13.9%
Accrued liabilities and other current	——	——	——	——	——
Other Commercial Liabilities	$8.48M-20.2%	$10.63M-7.9%	$11.54M+8.6%	$10.63M+1.3%	$10.49M+35.0%
Accrued Liabilities, Current	$8.48M-20.2%	$10.63M-7.9%	$11.54M+8.6%	$10.63M+1.3%	$10.49M+35.0%
Revolving credit facility	$441K-95.9%	$10.86M-4.0%	$11.31M-5.8%	$12.01M+6.6%	$11.26M-7.1%
Disposal Group - Accrued Liabilities	——	——	——	——	——
Line of Credit Outstanding	$441K-95.9%	$10.86M-4.0%	$11.31M-5.8%	$12.01M+6.6%	$11.26M-7.1%
Debt Maturity - 2025	——	——	——	——	——
Debt - Unamortized Discount (Premium) and Issuance Costs, Net	$249K-14.4%	$291K-11.8%	$330K-11.1%	$371K-6.3%	$396K-7.3%
Accrued taxes and other expenses	——	——	——	——	——
Total debt	$15M-16.0%	$17.86M-15.7%	$21.18M-15.5%	$25.07M+8.8%	$23.03M0.0%
Common Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Common Stock Shares Issued	140.1M0.0%	140M0.0%	140M+0.5%	139.3M+0.2%	139.1M0.0%
Convertible Preferred Stock Authorized Shares	10M0.0%	10M0.0%	10M0.0%	10M0.0%	10M0.0%
Convertible Preferred Stock Issued Shares	0—	0—	0—	0—	0—
Convertible Preferred Stock Outstanding Shares	0—	0—	0—	0—	0—
Preferred Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Cumulative Cost Basis	$28.3M-0.4%	$28.41M-10.9%	$31.87M+0.8%	$31.62M+1.3%	$31.23M+4.2%
Deferred Revenue Timing Percentage	——	——	——	——	——
Accounts And Financing Receivable Allowance For Credit Loss	$2.12M-2.3%	$2.17M+6.9%	$2.03M—	——	——
Allowance for doubtful accounts	——	——	——	——	$1.71M+18.6%
Cash and cash equivalents, end of period	$12.16M-29.8%	$17.33M+62.8%	$10.64M+51.2%	$7.04M+29.5%	$5.44M-12.6%
Common stock, par value (in dollars per share)	$00.0%	$00.0%	$00.0%	$00.0%	$00.0%
Common stock, shares authorized (in shares)	$300M0.0%	$300M0.0%	$300M0.0%	$300M0.0%	$300M0.0%
Common stock, shares issued (in shares)	$140.07M0.0%	$140.04M0.0%	$140M+0.5%	$139.32M+0.2%	$139.08M0.0%
Common Stock, Shares, Outstanding	$140.07M0.0%	$140.04M0.0%	$140M+0.5%	$139.32M+0.2%	$139.08M0.0%
Deferred Tax Liabilities, Gross	——	——	——	——	——
Deferred income taxes	——	——	——	——	——
Deferred Tax Assets, Charitable Contribution Carryforwards	——	——	——	——	——
Deferred Tax Assets, Gross	——	——	——	——	——
Deferred Tax Assets, Net	——	——	——	——	——
Deferred Tax Assets, Operating Loss Carryforwards	——	——	——	——	——
U.S. federal, state and foreign net operating loss, credit carryforwards and other carryforwards	——	——	——	——	——
Deferred Tax Assets, Operating Loss Carryforwards, State and Local	——	——	——	——	——
R&D credit carryforward	——	——	——	——	——
Deferred Tax Assets Tax Deferred Expense Amortization	——	——	——	——	——
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses	——	——	——	——	——
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost	——	——	——	——	——
Deferred Tax Assets Tax Deferred Expense Interest Expense	——	——	——	——	——
Deferred Tax Assets Tax Deferred Expense Lease Liability	——	——	——	——	——
Other	——	——	——	——	——
Powder Metal Matter	——	——	——	——	——
Accrued expenses	——	——	——	——	——
Deferred Tax Assets Tax Deferred Expense Uniform Capitalization	——	——	——	——	——
Deferred Tax Assets, Valuation Allowance	——	——	——	——	——
Deferred Tax Liabilities Depreciation	——	——	——	——	——
Prepaid expenses	——	——	——	——	——
Deferred Tax Liability Right Use Of Asset	——	——	——	——	——
Disposal Group Including Discontinued Operation Accounts Payable	——	——	——	——	——
Prepaid expenses and other current assets	——	——	——	——	——
Property, plant and equipment — net	——	——	——	——	——
Disposal Group Including Discontinued Operation Right Of Use Asset Net	——	——	——	——	——
Current maturities of long-term debt	$35K0.0%	$35K-20.5%	$44K-15.4%	$52K-14.8%	$61K-11.6%
Finite Lived Intangible Assets Amortization Expense Rolling After Year Five	——	——	——	——	——
Finite Lived Intangible Assets Amortization Expense Rolling Year Three	——	——	——	——	——
Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months	——	——	——	——	——
Finite Lived Intangible Assets Amortization Expense Rolling Year Four	——	——	——	——	——
Finite Lived Intangible Assets Amortization Expense Rolling Year Two	——	——	——	——	——
Finite Lived Intangible Assets Amortization Expense Rolling Year Five	——	——	——	——	——
Indefinite Carryforward Available To Offset Taxable Income Percentage	——	——	——	——	——
Issued And Outstanding Shares Of Equity Securitiespercentage	——	——	——	——	——
Secured lines of credit	$11.16M-20.3%	$14M-17.6%	$17M-22.7%	$22M0.0%	$22M0.0%
Loans Payable, Noncurrent	$905K+10.8%	$817K+11.3%	$734K+13.1%	$649K+15.3%	$563K+21.1%
Other accrued liabilities	$407K-76.3%	$1.72M-57.1%	$4M+5.4%	$3.79M-8.6%	$4.15M+130%
Preferred Stock, Par or Stated Value Per Share	$00.0%	$00.0%	$00.0%	$00.0%	$00.0%
Preferred Stock, Shares Authorized	$10M0.0%	$10M0.0%	$10M0.0%	$10M0.0%	$10M0.0%
Preferred Stock, Shares Issued	$0—	$0—	$0—	$0—	$0—
Preferred Stock, Shares Outstanding	$0—	$0—	$0—	$0—	$0—
Unamortized Debt Issuance Expense	$249K-14.4%	$291K-11.8%	$330K-11.1%	$371K-6.3%	$396K-7.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Xtant Medical Holdings.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Xtant Medical Holdings's total assets?: Xtant Medical Holdings (XTNT) holds $78.0M in total assets, down 18.6% year over year.
How much debt does Xtant Medical Holdings have?: Xtant Medical Holdings carries $15.0M in total debt against $48.6M of shareholders' equity, a debt-to-equity ratio of 0.31.
How much cash does Xtant Medical Holdings have?: Xtant Medical Holdings holds $12.2M in cash and equivalents.
Can Xtant Medical Holdings cover its short-term obligations?: Its current ratio is 3.34 — current assets exceed current liabilities.
Where does Xtant Medical Holdings's balance sheet data come from?: Every line is extracted from Xtant Medical Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.